secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2022-11-07T23:59:59+00:00
Accession:  0001077183-22-000163
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics appoints David Perez to board, Warren Stone as clinical services president
--------------------------------------------------------------------------------

- David B. Perez appointed to Board effective Nov 3, 2022; term until 2023 annual meeting.
- Warren Stone appointed President, Clinical Services Division effective Nov 21, 2022, replacing Dr. David Sholehvar.
- Stone's compensation: $525K base, 50% target bonus, $1M annual equity, $350K sign-on cash, $2M sign-on equity, $250K relocation.
- Perez is former Terumo BCT CEO; brings 40 years of global executive leadership experience in medical devices and healthcare.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000107718322000163/0001077183-22-000163-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000107718322000163/neo-20221102.htm
  HTML page:      https://secwatch.observer/filing/0001077183-22-000163

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer